ANDA 200882, held by Sun Pharm. Esomeprazole Sodium.
As of Nov 16, 2026, ANDA 200882 (Esomeprazole Sodium), held by Sun Pharm, was first approved by FDA on Mar 18, 2013, with 2 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 18, 2013 | Original application | Approved | None posted |
| Esomeprazole SodiumEQ 20MG BASE/VIAL · injectable;intravenous | Esomeprazole Sodium | Discontinued |
| Esomeprazole SodiumEQ 40MG BASE/VIAL · injectable;intravenous | Esomeprazole Sodium | Discontinued |
| Apr 14, 2015 | Supplement 2Labeling · Standard review | Approved | None posted |
| Apr 14, 2015 | Supplement 3Labeling · Standard review | Approved | None posted |
| Mar 18, 2013 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters